CareLabs Q1 2026 Results: Operating Profit Turns Positive, Net Loss Continues


  • Consolidated revenue of 20.5 billion KRW, down 11% YoY (23.1 billion in Q1 2025)
  • Consolidated operating profit of 0.67 billion KRW (Q1 2025: segment profit 2.3 billion, but excluding one-time gain would be a loss)
  • Net loss attributable to parent of 0.61 billion KRW (Q1 2025: net profit of 25.4 billion including real estate sale gain)
  • RCPS liabilities of 9.6 billion KRW, with interest expense of 0.22 billion
  • Land purchase commitments for senior business of 137.1 billion and new HQ construction of 5.3 billion underway
  • One lawsuit as plaintiff (amount 0.57 billion)
  • No dividends for common shareholders (non-controlling dividend of 0.54 billion separate)

KOSDAQ Filing Information


  • Filing: Quarterly Report (2026.03)
  • Company: Carelabs (263700)
  • Submission: Carelabs Co.,Ltd
  • Receipt: 05-15-2026